Skip to main content
Therma Bright Inc. logo

Therma Bright Inc. — Investor Relations & Filings

Ticker · THRM ISIN · CA8834262070 LEI · 529900PN7P0GSORO2174 TSXV Manufacturing
Open in API
Filings indexed 525 across all filing types
Latest filing 2021-02-18 AGM Information
Country CA Canada
Listing TSXV THRM

About Therma Bright Inc.

https://www.thermabright.com/

Therma Bright Inc. is a medical technology company that develops, acquires, and markets proprietary diagnostic and medical device technologies for the consumer and institutional healthcare sectors. The company's portfolio addresses key areas including pain management, circulation, diagnostics, and critical care. Core products and development projects include Venowave, a medical device designed to boost circulation and prevent blood clots; the Digital Cough Test (DCT), an AI-powered application developed with AI4LYF for rapid, non-invasive detection of respiratory diseases; and the PREVA™ clot retriever, developed with Inretio for enhanced thrombectomy procedures in ischemic stroke treatment. Furthermore, Therma Bright is advancing inhaled statin therapy in partnership with InVixa for the treatment of COVID-19 pneumonia and Acute Respiratory Distress Syndrome (ARDS).

Recent filings

Filing Released Lang Actions
Management information circular - English.pdf
AGM Information Classification · 100% confidence The document is titled 'Management Information Circular' and is related to the solicitation of proxies for the Annual General Meeting (AGM) of Therma Bright Inc. It includes detailed instructions on proxy appointment, voting procedures, record date, and meeting logistics. The content is typical of materials sent to shareholders ahead of an AGM to inform them about the meeting and solicit their votes. It is not a report of financial results, audit, or management discussion, nor is it a transcript or announcement of voting results. The document is not a brief announcement but a comprehensive circular for the AGM. Therefore, it fits the category of AGM Information (AGM-R).
2021-02-18 English
Other.pdf
AGM Information Classification · 95% confidence The document is a Voting Instruction Form (VIF) related to the Annual General Meeting (AGM) of Therma Bright Inc. It contains instructions for shareholders on how to vote on various matters at the AGM, including election of directors and appointment of auditors. The content is focused on proxy voting instructions rather than the actual AGM materials or presentations. This type of document is typically classified as AGM Information (AGM-R) because it is part of the materials shared in connection with the AGM, specifically proxy and voting instructions.
2021-02-18 English
Material change report - English.pdf
Capital/Financing Update Classification · 95% confidence The document is titled 'FORM 51-102F3 MATERIAL CHANGE REPORT' and details a material change involving the exercise of warrants and options adding $1,171,875 to the company's treasury. It includes a summary and full description of the material change, the date of the change, and contact information for the executive officer. The content focuses on a financing event (exercise of warrants and options) that affects the company's capital structure. There are no financial statements or comprehensive financial performance data, so it is not an Annual Report or Interim Report. It is not a regulatory certification or officer attestation. The document is a formal announcement of a material change related to capital raising activities. According to the filing definitions, updates on company fundraising or capital structure changes fall under 'Capital/Financing Update (CAP)'. The document length is just over 5,000 characters, containing substantive information about the financing event, not merely a notice or link to a report. Therefore, the appropriate classification is CAP with high confidence.
2021-02-01 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that Therma Bright Inc. has raised $1,171,875 through the exercise of warrants and options, adding to the company's treasury. It discusses the use of these funds and provides company background and forward-looking statements. There are no financial statements, detailed financial performance data, or regulatory form references. The document is short (4229 characters) and serves as a capital/financing update rather than a full financial report or earnings release. Therefore, it fits best under Capital/Financing Update (CAP).
2021-01-29 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 51-102F3 MATERIAL CHANGE REPORT' and details a material change event for Therma Bright Inc., specifically the acquisition of 100% control of its COVID-19 rapid saliva antigen test and related corporate updates. It includes a news release, summary, and full description of the material change, along with forward-looking statements and regulatory disclaimers. The content is focused on announcing a significant corporate event rather than providing financial statements or detailed financial performance data. The document is a regulatory filing reporting a material change as required by securities regulations, not an annual or quarterly report, earnings release, or other financial report. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2021-01-25 English
News release - English.pdf
Capital/Financing Update Classification · 90% confidence The document is a press release announcing that Therma Bright has acquired full control of its COVID-19 rapid saliva antigen test and is proposing a name change for the test. It includes corporate updates about regulatory approvals, manufacturing plans, and debt settlements. The document does not contain financial statements, detailed financial performance data, or regulatory filings. It is primarily an operational and corporate update about product control and commercialization plans. There is no indication that this is an earnings release, annual or interim report, or any other formal financial filing. The content fits best as a general corporate announcement about business developments and financing arrangements. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2021-01-25 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.